Kirill Osipov comments on regulation of dependent inventions in Russia

Mr. Kirill Osipov, the Head of Legal Department, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.

More details are available at Pharmvestnik’s website.

Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.

Make an enquiry

Latest News

Kirill Osipov commented on the recent invalidation of yet another patent of Russian generic producer «Nativa»

2019-02-11

«Pharmaceutical Bulletin» – one of the largest professional magazines devoted to Russian pharma – published an article on the recent invalidatio...

Read more
On the establishment of the Eurasian trademark and appellation of origin system

2019-02-08

About three years ago the Eurasian Economic Commission, the regulatory body of the Eurasian Economic Union (hereinafter - EAEU), adopted a draft treat...

Read more

View all our News

MEET WITH US

Meet with us at AIPLA 2018 Annual Meeting

2018-10-05

Mikhail Khmara, Managing Partner of ARS-Patent & Trademark and the Head of Patent Department, will be attending AIPLA 2018 Annual Meeting on Octo...

Read more
Vladimir Rybakov will attend the 2018 AIPPI World Congress in Cancun, Mexico

2018-09-06

Vladimir Rybakov, the senior partner of “ARS-Patent & Trademark”, will attend the 2018 AIPPI World Congress in Cancun, Mexico, September 23-26...

Read more

See all Events

Back top